Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Balance Sheet

GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Balance Sheet History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
EQUITY AND LIABILITIES
Share Capital ₹28 Cr₹28 Cr₹28 Cr₹28 Cr₹28 Cr
    Equity - Authorised ₹237 Cr₹237 Cr₹237 Cr₹237 Cr₹237 Cr
    Equity - Issued ₹28 Cr₹28 Cr₹28 Cr₹28 Cr₹28 Cr
    Equity Paid Up ₹28 Cr₹28 Cr₹28 Cr₹28 Cr₹28 Cr
    Equity Shares Forfeited -----
    Adjustments to Equity -----
    Preference Capital Paid Up -----
    Face Value ₹1.00₹1.00₹1.00₹1.00₹1.00
Share Warrants & Outstandings ₹18 Cr₹18 Cr₹16 Cr₹22 Cr₹14 Cr
Total Reserves ₹7,801 Cr₹9,428 Cr₹9,042 Cr₹7,015 Cr₹6,029 Cr
    Securities Premium ₹1,687 Cr₹1,685 Cr₹1,685 Cr₹1,685 Cr₹1,685 Cr
    Capital Reserves ₹0.10 Cr₹0.10 Cr₹0.10 Cr₹0.10 Cr₹0.10 Cr
    Profit & Loss Account Balance ₹7,870 Cr₹9,457 Cr₹9,211 Cr₹7,234 Cr₹6,330 Cr
    General Reserves ₹146 Cr₹146 Cr₹146 Cr₹146 Cr₹146 Cr
    Other Reserves ₹-1,901 Cr₹-1,860 Cr₹-2,000 Cr₹-2,050 Cr₹-2,132 Cr
Reserve excluding Revaluation Reserve ₹7,801 Cr₹9,428 Cr₹9,042 Cr₹7,015 Cr₹6,029 Cr
Revaluation reserve -----
Shareholder's Funds ₹7,848 Cr₹9,474 Cr₹9,087 Cr₹7,065 Cr₹6,071 Cr
Minority Interest ₹-0.38 Cr₹365 Cr₹351 Cr₹-0.35 Cr₹-0.39 Cr
Long-Term Borrowings -----
Secured Loans -----
    Non Convertible Debentures -----
    Converible Debentures & Bonds -----
    Packing Credit - Bank -----
    Inter Corporate & Security Deposit -----
    Term Loans - Banks -----
    Term Loans - Institutions -----
    Other Secured -----
Unsecured Loans -₹3,852 Cr₹2,572 Cr₹3,889 Cr₹4,043 Cr
    Fixed Deposits - Public -----
    Loans and advances from subsidiaries -----
    Inter Corporate Deposits (Unsecured) -----
    Foreign Currency Convertible Notes --₹729 Cr₹1,017 Cr₹1,643 Cr
    Long Term Loan in Foreign Currency ₹157 Cr₹2,806 Cr₹2,572 Cr₹2,095 Cr-
    Loans - Banks -₹1,191 Cr-₹1,062 Cr₹1,295 Cr
    Loans - Govt. -----
    Loans - Others ----₹1,488 Cr
    Other Unsecured Loan ₹-157 Cr₹-146 Cr₹-729 Cr₹-286 Cr₹-383 Cr
Deferred Tax Assets / Liabilities ₹-1,049 Cr₹-1,805 Cr₹-1,655 Cr₹-1,506 Cr₹-1,439 Cr
    Deferred Tax Assets ₹1,432 Cr₹2,046 Cr₹1,938 Cr₹1,823 Cr₹1,754 Cr
    Deferred Tax Liability ₹383 Cr₹240 Cr₹283 Cr₹318 Cr₹315 Cr
Other Long Term Liabilities ₹692 Cr₹575 Cr₹352 Cr₹421 Cr₹429 Cr
Long Term Trade Payables -----
Long Term Provisions -----
Total Non-Current Liabilities ₹-357 Cr₹2,621 Cr₹1,270 Cr₹2,804 Cr₹3,033 Cr
Current Liabilities -----
Trade Payables ₹2,536 Cr₹2,000 Cr₹2,289 Cr₹2,238 Cr₹2,126 Cr
    Sundry Creditors ₹2,536 Cr₹2,000 Cr₹2,289 Cr₹2,238 Cr₹2,126 Cr
    Acceptances -----
    Due to Subsidiaries- Trade Payables -----
Other Current Liabilities ₹1,517 Cr₹1,605 Cr₹1,446 Cr₹886 Cr₹1,002 Cr
    Bank Overdraft / Short term credit -----
    Advances received from customers -----
    Interest Accrued But Not Due ₹4.40 Cr₹43 Cr₹14 Cr₹18 Cr₹19 Cr
    Share Application Money -----
    Current maturity of Debentures & Bonds -----
    Current maturity - Others -----
    Other Liabilities ₹1,513 Cr₹1,562 Cr₹1,433 Cr₹868 Cr₹982 Cr
Short Term Borrowings ₹833 Cr₹350 Cr₹370 Cr₹513 Cr₹443 Cr
    Secured ST Loans repayable on Demands -----
    Working Capital Loans- Sec -----
    Buyers Credits - Unsec -----
    Commercial Borrowings- Unsec -----
    Other Unsecured Loans ₹833 Cr₹350 Cr₹370 Cr₹513 Cr₹443 Cr
Short Term Provisions ₹932 Cr₹591 Cr₹585 Cr₹564 Cr₹556 Cr
    Proposed Equity Dividend -----
    Provision for Corporate Dividend Tax -----
    Provision for Tax ₹291 Cr₹98 Cr₹93 Cr₹50 Cr₹41 Cr
    Provision for post retirement benefits ₹101 Cr₹88 Cr₹98 Cr₹115 Cr₹112 Cr
    Preference Dividend -----
    Other Provisions ₹540 Cr₹404 Cr₹394 Cr₹399 Cr₹403 Cr
Total Current Liabilities ₹5,819 Cr₹4,546 Cr₹4,689 Cr₹4,201 Cr₹4,126 Cr
Total Liabilities ₹13,309 Cr₹17,566 Cr₹15,397 Cr₹14,069 Cr₹13,229 Cr
ASSETS
Gross Block ₹9,620 Cr₹10,360 Cr₹10,213 Cr₹8,732 Cr₹8,270 Cr
Less: Accumulated Depreciation ₹5,409 Cr₹4,938 Cr₹4,326 Cr₹3,603 Cr₹3,241 Cr
Less: Impairment of Assets -----
Net Block ₹4,210 Cr₹5,422 Cr₹5,887 Cr₹5,129 Cr₹5,029 Cr
Lease Adjustment A/c -----
Capital Work in Progress ₹419 Cr₹1,066 Cr₹921 Cr₹1,218 Cr₹1,091 Cr
Non Current Investments ₹790 Cr₹45 Cr₹50 Cr₹25 Cr₹25 Cr
Long Term Investment ₹790 Cr₹45 Cr₹50 Cr₹25 Cr₹25 Cr
    Quoted ₹745 Cr₹0.07 Cr₹0.05 Cr₹0.07 Cr₹0.03 Cr
    Unquoted ₹45 Cr₹45 Cr₹50 Cr₹25 Cr₹25 Cr
Long Term Loans & Advances ₹212 Cr₹181 Cr₹161 Cr₹146 Cr₹124 Cr
Other Non Current Assets ₹7.42 Cr₹3.46 Cr₹6.70 Cr₹28 Cr₹26 Cr
Total Non-Current Assets ₹5,881 Cr₹6,840 Cr₹7,115 Cr₹6,709 Cr₹6,425 Cr
Current Assets Loans & Advances -----
Currents Investments -----
    Quoted -----
    Unquoted -----
Inventories ₹2,513 Cr₹2,374 Cr₹2,500 Cr₹2,277 Cr₹2,136 Cr
    Raw Materials ₹580 Cr₹649 Cr₹703 Cr₹528 Cr₹635 Cr
    Work-in Progress ₹103 Cr₹84 Cr₹402 Cr₹439 Cr₹361 Cr
    Finished Goods ₹1,193 Cr₹1,020 Cr₹846 Cr₹839 Cr₹725 Cr
    Packing Materials ₹314 Cr₹298 Cr₹269 Cr₹230 Cr₹193 Cr
    Stores  and Spare ₹111 Cr₹114 Cr₹104 Cr₹107 Cr₹85 Cr
    Other Inventory ₹213 Cr₹209 Cr₹174 Cr₹133 Cr₹136 Cr
Sundry Debtors ₹1,858 Cr₹3,665 Cr₹3,101 Cr₹2,572 Cr₹2,409 Cr
    Debtors more than Six months ₹396 Cr₹363 Cr₹302 Cr₹396 Cr-
    Debtors Others ₹1,593 Cr₹3,443 Cr₹2,929 Cr₹2,283 Cr₹2,505 Cr
Cash and Bank ₹1,659 Cr₹1,160 Cr₹1,412 Cr₹1,139 Cr₹1,111 Cr
    Cash in hand ₹0.98 Cr₹1.04 Cr₹1.69 Cr₹1.61 Cr₹1.66 Cr
    Balances at Bank ₹1,658 Cr₹1,159 Cr₹1,410 Cr₹1,138 Cr₹1,110 Cr
    Other cash and bank balances -----
Other Current Assets ₹178 Cr₹317 Cr₹297 Cr₹671 Cr₹603 Cr
    Interest accrued on Investments -----
    Interest accrued on Debentures -----
    Deposits with Government -----
    Interest accrued and or due on loans -----
    Prepaid Expenses ₹27 Cr₹227 Cr₹220 Cr₹220 Cr₹146 Cr
    Other current_assets ₹152 Cr₹89 Cr₹78 Cr₹451 Cr₹458 Cr
Short Term Loans and Advances ₹1,219 Cr₹908 Cr₹972 Cr₹700 Cr₹544 Cr
    Advances recoverable in cash or in kind ₹526 Cr₹382 Cr₹457 Cr₹633 Cr₹508 Cr
    Advance income tax and TDS ----₹2.65 Cr
    Amounts due from directors -----
    Due From Subsidiaries -----
    Inter corporate deposits -----
    Corporate Deposits -----
    Other Loans & Advances ₹693 Cr₹526 Cr₹516 Cr₹68 Cr₹34 Cr
Total Current Assets ₹7,428 Cr₹8,424 Cr₹8,282 Cr₹7,360 Cr₹6,804 Cr
Net Current Assets (Including Current Investments) ₹1,609 Cr₹3,877 Cr₹3,593 Cr₹3,159 Cr₹2,678 Cr
Miscellaneous Expenses not written off -----
Total Assets ₹13,309 Cr₹17,566 Cr₹15,397 Cr₹14,069 Cr₹13,229 Cr
Contingent Liabilities ₹1,063 Cr₹337 Cr₹361 Cr₹384 Cr₹271 Cr
Total Debt ₹991 Cr₹4,348 Cr₹3,670 Cr₹4,687 Cr₹4,869 Cr
Book Value -335.13321.45249.60214.65
Adjusted Book Value 277.46335.13321.45249.60214.65

Compare Balance Sheet of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹41,680.9 Cr -6.9% -0.2% 70.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹421,527.0 Cr -3.7% -2.5% 31.9% Stock Analytics
DIVIS LABORATORIES ₹156,037.0 Cr 2.3% 2.1% 46.9% Stock Analytics
CIPLA ₹116,854.0 Cr -3.2% 0% 8.2% Stock Analytics
DR REDDYS LABORATORIES ₹111,746.0 Cr -2.4% 7.3% 15.3% Stock Analytics
ZYDUS LIFESCIENCES ₹99,093.9 Cr 2% 2.3% 37.9% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-6.9%

-0.2%

70.3%

SENSEX

-1.8%

-6.6%

7.1%


You may also like the below Video Courses